NIH Aims to Out-License Endometrial Cancer Detection Assay

Researchers at the National Cancer Institute have developed and optimized an ISH assay to detect miRNAs in fresh cell lines, and it can be adapted to work with frozen cells and tissue samples.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.